Minapharm Pharmaceuticals reported consolidated and standalone earnings results for the first quarter ended March 2020. On consolidated basis, the company's reported a 77.3% year-on-year (YoY) profit growth to EGP 75.25 million during the first quarter of 2020, compared to EGP 42.42 million, including minority shareholders' rights. The company's net sales amounted to EGP 551.01 million in the January-March period from EGP 522.19 million in the prior-year period. The company's standalone financial results showed net profits of EGP 18.5 million, up by 185% year-on-year from EGP 6.48 million.